These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9516853)

  • 21. The mycN/max protein complex in neuroblastoma. Short review.
    Wenzel A; Schwab M
    Eur J Cancer; 1995; 31A(4):516-9. PubMed ID: 7576956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
    Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
    Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma.
    Chen ST; Jeng YM; Chang CC; Chang HH; Huang MC; Juan HF; Hsu CH; Lee H; Liao YF; Lee YL; Hsu WM; Lai HS
    Cancer Sci; 2011 Dec; 102(12):2191-8. PubMed ID: 21917080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
    Slack A; Chen Z; Tonelli R; Pule M; Hunt L; Pession A; Shohet JM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):731-6. PubMed ID: 15644444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wild-type sequence of MYCN in neuroblastoma cell lines.
    Hogarty MD; Brodeur GM
    Int J Cancer; 1999 Feb; 80(4):630-1. PubMed ID: 9935168
    [No Abstract]   [Full Text] [Related]  

  • 28. RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.
    Yu F; Gao W; Yokochi T; Suenaga Y; Ando K; Ohira M; Nakamura Y; Nakagawara A
    Oncogene; 2014 May; 33(20):2601-9. PubMed ID: 23851507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
    Tanaka N; Fukuzawa M
    Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
    Lutz W; Fulda S; Jeremias I; Debatin KM; Schwab M
    Oncogene; 1998 Jul; 17(3):339-46. PubMed ID: 9690515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
    Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
    Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA localization by a 145-nucleotide region of the c-fos 3'--untranslated region. Links to translation but not stability.
    Dalgleish G; Veyrune JL; Blanchard JM; Hesketh J
    J Biol Chem; 2001 Apr; 276(17):13593-9. PubMed ID: 11139568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered growth and phenotype in clonal mycN transfectants of the SK-N-SH neuroblastoma cell line.
    Gross N; Miescher G; Beck D; Favre S; Beretta C
    Int J Cancer; 1994 Oct; 59(1):141-8. PubMed ID: 7927894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.
    Hossain S; Takatori A; Nakamura Y; Suenaga Y; Kamijo T; Nakagawara A
    Cancer Res; 2012 Sep; 72(17):4587-96. PubMed ID: 22815527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.
    Cohn SL; London WB; Huang D; Katzenstein HM; Salwen HR; Reinhart T; Madafiglio J; Marshall GM; Norris MD; Haber M
    J Clin Oncol; 2000 Nov; 18(21):3604-13. PubMed ID: 11054433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.